Abdelwhab E.M., Veits J., Mettenleiter T.C. (2017), Biological fitness and natural selection of amantadine resistant variants of avian influenza H5N1 viruses, Virus Research. 228:109-113.
Azab A.A., Arafa A., Selim A., Hassan M.K., Bazid A.I., Sultan A.H., Hussein H.A., Abdelwhab E.M. (2017), Pathogenicity of the Egyptian A/H5N1 avian influenza viruses in chickens, Microb Pathogenesis. (2017) 110:471-476.
Bertram S, Thiele S, Dreier C, Resa-Infante P, Preuß A, van Riel D, Mok CK, Schwalm F, PeirisJS, Klenk HD, Gabriel G (2017). H7N9 Influenza A Virus Exhibits Importin-α7-Mediated Replication in the Mammalian Respiratory Tract. Am J Pathol. 2017 Apr;187(4):831-840.
Bulanova D, Ianevski A, Bugai A, Akimov Y, Kuivanen S, Paavilainen H, Kakkola L, Nandania J, Turunen L, Ohman T, Ala-Hongisto H, (...), Gabriel G, (...), Velagapudi V, Kainov DE (2017). Antiviral Properties of Chemical Inhibitors of Cellular Anti-Apoptotic Bcl-2 Proteins. Viruses. 2017 Sep 25;9(10).
Bhatia S, Lauster D, Bardua M, Ludwig K, Angioletti-Uberti S, Popp N, Hoffmann U, Paulus F, Budt M, Stadtmüller M, Wolff T, Hamann A, Böttcher C, Herrmann A and R Haag. Linear polysialoside outperforms dendritic analogs for inhibition of influenza virus infection in vitro and in vivo. Biomaterials 2017 Sep;138:22-34.
Cavalcanti M.O., Vaughn E., Capua I., Cattoli G., Terregino C., Harder T., Grund C., Vega C., Robles F., Franco J., Darji A., Arafa A.-S., Mundt E., A genetically engineered H5 protein expressed in insect cells confers protection against different clades of H5N1 highly pathogenic avian influenza viruses in chickens, Avian Pathology. (2017) 46:224-233.
Ciminski K, Thamamongood T, Zimmer G, Schwemmle M. (2017) Novel insights into bat influenza A viruses. J Gen Virol. 2017 Oct;98(10):2393-2400.Coch C, Stümpel JP, Lilien-Waldau V, Wohlleber D, Kümmerer BM, Bekeredjian-Ding I, Kochs G, Garbi N, Herberhold S, Schuberth-Wagner C, Ludwig J, Barchet W, Schlee M, Hoerauf A, Bootz F, Staeheli P, Hartmann G, Hartmann E. (2017) RIG-I Activation Protects and Rescues from Lethal Influenza Virus Infection and Bacterial Superinfection. Mol Ther. 2017 Sep 6;25(9):2093-2103.Berg J, Zscheppang K, Fatykhova D, Tönnies M, Bauer TT, Schneider P, Neudecker J, Rückert JC, Eggeling S, Schimek M, Gruber AD, Suttorp N, Hippenstiel S, Hocke AC. (2017) Tyk2 as a target for immune regulation in human viral/bacterial pneumonia.Eur Respir J. 2017 Jul 13;50(1).
Bloes DA, Haasbach E, Hartmayer C, Hertlein T, Klingel K, Kretschmer D, Planz O, Peschel A. Phenol-Soluble Modulin Peptides Contribute to Influenza A Virus-Associated Staphylococcus aureus Pneumonia. Infect Immun. 2017 Nov17;85(12). pii: e00620-17.
Boergeling Y, Ludwig S. (2017) Targeting a metabolic pathway to fight the flu. FEBS J. 2017 Jan;284(2):218-221. doi: 10.1111/febs.13997.Conraths F.J., Globig A., Sauter-Louis C., Dietze K., Homeier-Bachmann T., Probst C., Gethmann J., Depner K., Wysocki P., Reimer N., Staubach C., Grund C., Harder T., Starick E., Pohlmann A., Höper D., Beer M., Mettenleiter T.C., Making worst case scenarios real: The introduction of highly pathogenic avian influenza of subtype H5N8 led to the largest fowl plague outbreak ever recorded in Germany, Lohmann Information. (2017) 51:36-41.
Deeg CM, Hassan E, Mutz P, Rheinemann L, Götz V, Magar L, Schilling M,Kallfass C, Nürnberger C, Soubies S, Kochs G, Haller O, Schwemmle M, Staeheli P. In vivo evasion of MxA by avian influenza viruses requires human signature in the viral nucleoprotein. J Exp Med. 2017 May 1;214(5):1239-1248.
Dietert K, Gutbier B, Wienhold SM, Reppe K, Jiang X, Yao L, Chaput C, Naujoks J, Brack M, Kupke A, Peteranderl C, Becker S, von Lachner C, Baal N, Slevogt H, Hocke AC, Witzenrath M, Opitz B, Herold S, Hackstein H, Sander LE, Suttorp N, Gruber AD. (2017)Spectrum of pathogen- and model-specific histopathologies in mouse models of acute pneumonia. PLoS One. 2017 Nov 20;12(11):e0188251.
Dietzel E, Schudt G, Krahling V, Matrosovich M, Becker S. (2017). Functional characterization of adaptive mutations during the West African Ebola virus outbreak. J Virol. 91(2). pii: e01913-16. doi: 10.1128/JVI.01913-16.
Dou D, Hernández-Neuta I, Wang H, Östbye H, Qian X, Thiele S, Resa-Infante P, Kouassi NM, Sender V, Hentrich K, Mellroth P, Henriques-Normark B, Gabriel G,Nilsson M, Daniels R (2017). Analysis of IAV Replication and Co-infection Dynamics by a Versatile RNA Viral Genome Labeling Method. Cell Rep. 2017 Jul 5;20(1):251-263.
Drakopoulos A, Tzitzoglaki C, Ma C, Freudenberger K, Hoffmann A, Hu Y, Gauglitz G, Schmidtke M, Wang J, Kolocouris A. (2017) Affinity of rimantadine enantiomers against Influenza A/M2 protein revisited. ACS Med Chem Lett. 2017 Jan 27;8(2):145-150. doi: 10.1021/acsmedchemlett.6b00311. eCollection 2017
Droebner K., Haasbach E., Dudek S.E., Scheuch G., Nocker K., Canisius S., Ehrhardt C., von Degenfeld G., Ludwig S., Planz O., Pmek, Pharmacokinetics, and Antiviral Activity of BAY 81-8781, a Novel NF-kB Inhibiting Anti-influenza Drug, Frontiers in Microbiology. (2017) 8:1-13.
Engels G, Hierweger AM, Hoffmann J, Thieme R, Thiele S, Bertram S, Dreier C, Resa-Infante P, Jacobsen H, Thiele K, Alawi M, Indenbirken D, Grundhoff A, Siebels S, Fischer N, Stojanovska V, Muzzio D, Jensen F, Karimi K, Mittrücker HW, Arck PC & Gabriel G (2017). Pregnancy-Related Immune Adaptation Promotes the Emergence of Highly Virulent H1N1 Influenza Virus Strains in Allogenically Pregnant Mice. Cell Host Microbe. 2017 Mar 8;21(3):321-333.
EFSA Panel on Animal Health and Welfare (AHAW), More S., Bicout D., Botner A., Butterworth A., Calistri P., Depner K., Edwards S., Garin-Bastuji B., Good M., Gortázar Schmidt C., Michel V., Miranda M.A., Nielsen S.S., Raj M., Sihvonen L., Spoolder H., Thulke H.-H., Velarde A., Willeberg P., Winckler C., Adlhoch C., Baldinelli F., Breed A., Brouwer A., Guillemain M., Harder T., Monne I., Roberts H., Cortinas Abrahantes J., Mosbach-Schulz O., Verdonck F., Morgado J., Stegeman A. Urgent request on avian influenza, EFSA Journal. (2017) 15:4687.
EFSA Panel on Animal Health and Welfare (AHAW), More S., Bicout D., Botner A., Butterworth A., Calistri P., Depner K., Edwards S., Garin-Bastuji B., Good M., Gortázar Schmidt C., Michel V., Miranda M.A., Nielsen S.S., Raj M., Sihvonen L., Spoolder H., Thulke H.-H., Velarde A., Willeberg P., Winckler C., Breed A.C., Brouwer A., Guillemain M., Harder T., Monne I., Roberts H., Baldinelli F., Barrucci F., Fabris C., Martino L., Mosbach-Schulz O., Verdonck F., Morgado J., Stegeman J.A., Thulke H.-H., Wikelski M., Daniel P., Fabri T., Gaidet N., Grabkowsky B., Guberti V., Guyot M., Hoefle U., Huneau Salaun A., Kuiken T., Meyer H., Michel V., Neghirla I., Niqueux É., Si Y., Slavec B., Smietanka K., Staubach C., Vescei A.L., Verhagen J., von Dobschuetz S., Adlhoch C., Consortium A., Bronner A., Avian influenza, EFSA Journal. (2017) 15:4991.
Gatti, D., French, J.E., and Schughart, K. (2017). QTL Mapping and Identification of Candidate Genes in DO Mice: A Use Case Model Derived from a Benzene Toxicity Experiment. Methods Mol Biol 1488, 265-281.
Gerlach T, Hensen L, Matrosovich T, Bergmann J, Winkler M, Peteranderl C, Klenk HD, Weber F, Herold S, Pohlmann S, Matrosovich M. (2017). pH optimum of hemagglutinin-mediated membrane fusion determines sensitivity of influenza A viruses to the interferon-induced antiviral state and IFITMs. J Virol;91(11). pii: e00246-17. doi: 10.1128/JVI.00246-17.
Giese S, Ciminski K, Bolte H, Moreira ÉA, Lakdawala S, Hu Z, David Q,Kolesnikova L, Götz V, Zhao Y, Dengjel J, Chin YE, Xu K, Schwemmle M.(2017)
Role of influenza A virus NP acetylation on viral growth and replication. Nat Commun. 2017 Nov 2;8(1):1259. doi: 10.1038/s41467-017-01112-3. PubMed PMID: 29097654.Globig A., Starick E., Homeier T., Pohlmann A., Grund C., Wolf P., Zimmermann A., Wolf C., Heim D., Schlößer H., Zander S., Beer M., Conraths F.J., Harder T.C., Epidemiological and Molecular Analysis of an Outbreak of Highly Pathogenic Avian Influenza h5N8 clade 2.3.4.4 in a German Zoo: Effective Disease Control with Minimal Culling, Transboundary and Emerging Diseases. (2017) 64:1813-1824.
Graaf A., Beer M., Harder T., Real-time reverse transcription PCR-based sequencing-independent pathotyping of Eurasian avian influenza A viruses of subtype H7, Virology Journal. (2017) 14:1-10.
Haasbach E, Müller C, Ehrhardt C, Schreiber A, Pleschka S, Ludwig S, Planz O. The MEK-inhibitor CI-1040 displays a broad anti-influenza virus activity in vitro and provides a prolonged treatment window compared to standard of care in vivo. Antiviral Res. 2017 Jun;142:178-184. doi: 10.1016/j.antiviral.2017.03.024. Epub 2017 Apr 2.
Haralampiev I, Schade M, Chamiolo J, Jolmes F, Prisner S, Witkowski PT, Behrent M, Hövelmann F, Wolff T, Seitz O, A Herrmann (2017). A fluorescent RNA forced-intercalation probe as a pan-selective marker for influenza A virus infection. ChemBioChem 2017 Aug 17;18(16):1589-1592.
Hatesuer, B., Hoang, H.T., Riese, P., Trittel, S., Gerhauser, I., Elbahesh, H., Geffers, R., Wilk, E., and Schughart, K. (2017). Deletion of Irf3 and Irf7 Genes in Mice Results in Altered Interferon Pathway Activation and Granulocyte-Dominated Inflammatory Responses to Influenza A Infection. J Innate Immun 9, 145-161.
Herrera-Rodriguez J, Meijerhof T, Niesters HG, Stjernholm G, Hovden AO, Sørensen B, Ökvist M, Sommerfelt MA, Huckriede A. A novel peptide-based vaccine candidate with protective efficacy against influenza A in a mouse model. Virology. 2017 Dec 7;515:21-28. doi: 10.1016/j.virol.2017.11.018. [Epub ahead of print]
Hocke AC, Suttorp N, Hippenstiel S. (2017)
Human lung ex vivo infection models.
Cell Tissue Res. 2017 Mar;367(3):511-524. doi: 10.1007/s00441-016-2546-z. Epub 2016 Dec 20. Review.
Hoffmann A, Richter M, von Grafenstein S, Walther E, Xu Z, Schumann L, GrienkeU, Mair CM, Rollinger JM, Liedl KR, Schmidtke M, Kirchmair J. Discovery and characterization of diazenylaryl sulfonic acids as inhibitors of viral and bacterial neuraminidases. Front Microbiol. 2017 8:205. Doi: 10.3389/fmicb.2017.00205
Holzberg M, Boergeling Y, Schräder T, Ludwig S, Ehrhardt C. (Accepted)
Vemurafenib Limits Influenza A Virus Propagation by Targeting Multiple Signaling Pathways
Front Microbiol.
Huckriede A. Immunoglobulin Infusion as Therapy Against Influenza? EBioMedicine. 2017 May;19:10-11. doi: 10.1016/j.ebiom.2017.04.021. Epub 2017 Apr 13.
Klemm C, Bruchhagen C, van Krüchten A, Niemann S, Löffler B, Peters G, Ludwig S, Ehrhardt C. (2017). Mitogen-activated protein kinases (MAPKs) regulate IL-6 over-production during concomitant influenza virus and Staphylococcus aureus infection.Sci Rep. 2017 Feb 14;7:42473. doi: 10.1038/srep42473.
Klemm C, Boergeling Y, Ludwig S, Ehrhardt C. (Accepted) Immunomodulatory non-structural proteins of influenza A viruses
Trends in Microbiology. Review.
Klingen T, Reimering S, Loers J, Mooren K, Klawonn F, Krey T, Gabriel G, McHardy A (2017). Sweep Dynamics (SD) plots: Computational identification of selective sweeps to monitor the adaptation of influenza A viruses. Scientific Reports, Nov 2017, accepted.
Lehmann C, Berner R, Bogner JR, Cornely OA, de With K, Herold S, Kern WV,Lemmen S, Pletz MW, Ruf B, Salzberger B, Stellbrink HJ, Suttorp N, Ullmann AJ,Fätkenheuer G, Jung N. The "Choosing Wisely" initiative in infectious diseases.https://www.ncbi.nlm.nih.gov/pubmed/28290130 Infection. 2017 Jun;45(3):263-268. doi: 10.1007/s15010-017-0997-0. Epub 2017 Mar 13. Review. PubMed PMID: 28290130.
Lopes AM, Domingues P, Zell R, Hale BG. 2017. Structure-guided functional annotation of the influenza A virus NS1 protein reveals dynamic evolution of the p85b-binding site during circulation in humans. J Virol 91(21):e01081-17. doi: 10.1128/JVI.01081-17.
Masemann D, Boergeling Y, and Ludwig S (2017) Employing RNA viruses to fight cancer - Novel insights into oncolytic virotherapy. Biol Chem. 398:891-909
Nacken W, Wixler V, Ehrhardt C, Ludwig S. (2017) Influenza A virus NS1 protein-induced JNK activation and apoptosis are not functionally linked.
Cell Microbiol. 2017 Jul;19(7). doi: 10.1111/cmi.12721. Epub 2017 Jan 27.
Naguib M.M., Arafa A.-S., Parvin R., Beer M., Vahlenkamp T.W., Harder T.C., Insights into genetic diversity and biological propensities of potentially zoonotic avian influenza H9N2 viruses circulating in Egypt, Virology. (2017) 511:165-174.
Naguib M.M., El-Kady M.F., Lüschow D., Hassan K.E., Arafa A.-S., El-Zanaty A., Hassan M.K., Hafez H.M., Grund C., Harder T.C., New real time and conventional RT-PCRs for updated molecular diagnosis of infectious bronchitis virus infection (IBV) in chickens in Egypt associated with frequent co-infections with avian influenza and Newcastle Disease viruses, Journal of Virological Methods. (2017) 245:19-27.
Naguib M.M., Graaf A., Fortin A., Luttermann C., Wernery U., Amarin N., Hussein H.A., Sultan H., Al Adhadh B., Hassan M.K., Beer M., Monne I., Harder T.C., Novel real-time PCR-based patho- and phylotyping of potentially zoonotic avian influenza A subtype H5 viruses at risk of incursion into Europe in 2017, Eurosurveillance. (2017) 22:1-12.
Naguib M.M., Grund C., Arafa A.-S., Abdelwhab E.-S.M., Beer M., Harder T.C., Heterologous post-infection immunity against Egyptian avian influenza virus (AIV) H9N2 modulates the course of subsequent infection by highly pathogenic AIV H5N1, but vaccination immunity does not, Journal of General Virology. (2017) 98:1169-1173
Naguib M.M., Ulrich R.G., Kasbohm E., Eng C.L.P., Hoffmann D., Grund C., Beer M., Harder T.C., Natural Reassortants of Potentially Zoonotic Avian Influenza Viruses H5N1 and H9N2 from Egypt Display Distinct Pathogenic Phenotypes in Experimentally Infected Chickens and Ferrets, Journal of Virology. (2017) 91:e01300-01317.
Nagy A., Mettenleiter T.C., Abdelwhab E.-S.M., A brief summary of the epidemiology and genetic relatedness of avian influenza H9N2 virus in birds and mammals in the Middle East and North Africa, Epidemiology and Infection. [on line] (2017)
Patil HP, Herrera Rodriguez J, de Vries-Idema J, Meijerhof T, Frijlink HW,Hinrichs WLJ, Huckriede A. Adjuvantation of Pulmonary-Administered Influenza Vaccine with GPI-0100 Primarily Stimulates Antibody Production and Memory B Cell Proliferation. Vaccines (Basel). 2017 Jul 27;5(3). pii: E19.
Peteranderl C, Sznajder JI, Herold S, Lecuona E. Inflammatory ResponsesRegulating Alveolar Ion Transport during Pulmonary Infections. Front Immunol.2017 Apr 18;8:446
Peteranderl C, Herold S. The Impact of the Interferon/TNF-RelatedApoptosis-Inducing Ligand Signaling Axis on Disease Progression in RespiratoryViral Infection and Beyond. Front Immunol. 2017 Mar 22;8:313. doi:10.3389/fimmu.2017.00313. eCollection 2017
Pohl MO, von Recum-Knepper J, Rodriguez-Frandsen A, Lanz C, Wolff T, Chanda SK, Stertz S (2017). Identification of Polo-like kinases as potential novel drug targets for influenza A virus. Scientific Reports 2017, 7(1):8629. doi: 10.1038/s41598-017-08942-7.
Pohlmann A., Starick E., Harder T., Höper D., Globig A., Staubach C., Dietze K., Grund C., Strebelow G., Ulrich R.G., Schinköthe J., Teifke J.P., Conraths F.J., Mettenleiter T.C., Beer M., Outbreaks among Wild Birds and Domestic Poultry Caused by Reassorted Influenza A(H5N8) Clade 2.3.4.4 Viruses, Germany, 2016, Emerging Infectious Diseases. (2017) 23:633-636.
Preusse, M., Schughart, K., and Pessler, F. (2017). Host Genetic Background Strongly Affects Pulmonary microRNA Expression before and during Influenza A Virus Infection. Front Immunol 8, 246.
Sadewasser A, Paki K, Eichelbaum K, Bogdanow B, Saenger S, Budt M, Lesch M, Hinz KP, Herrmann A, Meyer TF, Karlas A, Selbach M, Wolff T. Quantitative proteomic approach identifies Vpr binding protein as novel host factor supporting influenza A virus infections in human cells. Mol Cell Proteomics 2017 May;16(5):728-742
Sánchez-Aparicio M, Ayllon J, Leo-Macias A, Wolff T, and A García-Sastre. Subcellular localizations of RIG-I, TRIM25 and MAVS complexes (2017). Journal of Virology 91(2). pii: e01155-16.
Schierhorn KL, Jolmes F, Bespalowa J, Saenger S, Peteranderl Dzieciolowski J, Budt M, Pleschka S, Herrmann A, Herold S and T Wolff (2017) Influenza A virus virulence depends on two amino acids in the N-terminal domain of its NS1 protein facilitating inhibition of PKR. Journal of Virology Apr 28;91(10). pii: e00198-17
Schughart K., Williams R. W. (Editors). (2016). Systems Genetics. Methods and Protocols. Methods in Molecular Biology. Volume 1488 2017. Springer. ISBN: 978-1-4939-6425-3 (Print) 978-1-4939-6427-7 (Online).
Sims L.D., Harder T., Brown I.H., Gaidet N., Belot G., von Dobschuetz S., Karmata A., Kivaria F., Palamara E., Bruni M., Dauphin G., Raizman E., Lubroth J., Highly pathogenic H5 avian influenza in 2016 and 2017 – observations and future perspectives, in: Food and Agriculture Organization of the United Nations (Ed.), Focus on FAO, 2017, pp. 1-16.
Skevaki C, Hudemann C, Matrosovich M, Mobs C, Paul S, Wachtendorf A, Alhamwe BA, Potaczek DP, Hagner S, Gemsa D, Garn H, Sette A, Renz H. 2017. Influenza-derived peptides cross-react with allergens and provide asthma protection. J Allergy Clin Immunol doi:10.1016/j.jaci.2017.07.056. pii: S0091-6749(17)31744-X. doi: 10.1016/j.jaci.2017.07.056. [Epub ahead of print].
Tang BM, Shojaei M, Parnell GP, Huang S, Nalos M, Teoh S, O'Connor K, Schibeci S, Phu AL, Kumar A, Ho J, Meyers AFA, Keynan Y, Ball T, Pisipati A, Kumar A, Moore E, Eisen D, Lai K, Gillett M, Geffers R, Luo H, Gul F, Schreiber J, Riedel S, Booth D, McLean A, Schughart K. (2017). A novel immune biomarker IFI27 discriminates between influenza and bacteria in patients with suspected respiratory infection. Eur Respir J 49.
Tapia-Calle G, Stoel M, de Vries-Idema J, Huckriede A. Distinctive Responses in an In Vitro Human Dendritic Cell-Based System upon Stimulation with Different Influenza Vaccine Formulations. Vaccines (Basel). 2017 Aug 9;5(3). pii: E21.
Tzitzoglaki C, Wright A, Freudenberger K, Hoffmann A, Tietjen I, Stylianakis I, Kolarov F, Fedida D,Schmidtke M, Gauglitz G, Cross TA, Kolocouris A.Binding and Proton Blockage by Amantadine Variants of the Influenza M2WT and M2S31N Explained. J Med Chem. 2017 Mar 9;60(5):1716-1733. doi: 10.1021/acs.jmedchem.6b01115
Turkington HL, Juozapaitis M, Tsolakos N, Corrales-Aguilar E, Schwemmle M, Hale BG.(2017)Unexpected Functional Divergence of Bat Influenza Virus NS1 Proteins.J Virol. 2017 Dec 13. pii: JVI.02097-17. doi: 10.1128/JVI.02097-17. [Epub ahead of print]
van Doorn E, Pleguezuelos O, Liu H, Fernandez A, Bannister R, Stoloff G,Oftung F, Norley S, Huckriede A, Frijlink HW, Hak E. Evaluation of the immunogenicity and safety of different doses and formulations of a broad spectrum influenza vaccine (FLU-v) developed by SEEK: study protocol for a single-center, randomized, double-blind and placebo-controlled clinical phase IIb trial. BMC Infect Dis. 2017 Apr 4;17(1):241.
Van den Hoecke S, Ehrhardt K, Kolpe A, El Bakkouri K, Deng L, Grootaert H, Schoonooghe S, Smet A, Bentahir M, Roose K, Schotsaert M, Schepens B, Callewaert N, Nimmerjahn F, Staeheli P, Hengel H, Saelens X.(2017) Hierarchical and Redundant Roles of Activating FcγRs in Protection against Influenza Disease by M2e-Specific IgG1 and IgG2a Antibodies.J Virol. 2017 Mar 13;91(7). pii: e02500-16. doi:10.1128/JVI.02500-16. Print 2017 Apr 1. van de Sandt CE, Bárcena M, Koster AJ, Kasper J, Kirkpatrick CJ, Scott DP, de Vries RD, Herold S, Rimmelzwaan GF, Kuiken T, Short KR. Human CD8(+) T Cells Damage Noninfected Epithelial Cells during Influenza Virus Infection In Vitro. Am J Respir Cell Mol Biol. 2017 Nov;57(5):536-546. doi: 10.1165/rcmb.2016-0377OC.
van Krüchten A, Wilden J, Niemann S, Peters G, Löffler B, Ludwig S, Ehrhardt C. (Accepted) Staphylococcus aureus triggers a shift from influenza virus-induced apoptosis to necrotic cell death
The FASEB Journal
Yang W., Punyadarsaniya D., Lambertz R.L.O., Lee D.C.C., Liang C.H., Höper D., Leist S.R., Hernández-Cáceres A., Stech J., Beer M., Wu C.Y., Wong C.H., Schughart K., Meng F., Herrler G., Mutations during the adaptation of H9N2 avian influenza virus to the respiratory epithelium of pigs enhance the sialic acid binding activity and the virulence in mice, Journal of Virology. (2017) 91:e02125-02116.